Skip to content

Eos Energy Enterprises, Inc. EOSE Proceeds From Issuance Of Warrants

Proceeds From Issuance Of Warrants at other companies

LCI Industries logo
LCI IndustriesLCII
$0-100%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1K-99.8%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$56.25K
Navan, Inc.
 logo
Navan, Inc. NAVN
$0-100%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$0-100%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$0-100%

Other financials

Income statement

See full
Revenue$57.0M+445%
Gross profit-$44.4M-81.0%
Operating income-$79.3M-49.8%
Net income$508.9M+3,262%
EPS (diluted)$0.12+160%

Balance sheet

See full
Cash & equivalents$472.4M+323%
Total debt$642.9M+95.6%
Total equity-$868.4M+7.8%
Total assets$799.3M+204%

Cash flow

See full
Operating cash flow-$119.7M-314%
CapEx$35.1M+613%
Free cash flow-$154.8M-357%

Valuation

See full
Market cap$2.2B+96.2%
Enterprise value$2.37B+72.5%
P/S13.7×-44.0×

Profitability

See full
Gross margin-101.9%-44.3pp
Operating margin-177.7%-79.8pp
Net margin-296.1%-141pp
FCF margin-240.1%-102pp

Returns & leverage

See full
Return on equity-162.1%
Debt / equity0.5×
Current ratio4.7×+2.7×

Where this comes from

Reported directly by Eos Energy Enterprises, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.

The official record: Eos Energy Enterprises, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eos Energy Enterprises, Inc.'s proceeds from issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eos Energy Enterprises, Inc.'s proceeds from issuance of warrants?
Eos Energy Enterprises, Inc. (EOSE) reported proceeds from issuance of warrants of $1.82M in Q4 2025.
What does proceeds from issuance of warrants mean?
This represents the cash inflows received from the issuance of warrants, which grant holders the right to purchase company stock at a specified price. It serves as a source of capital that can strengthen the balance sheet and provide future liquidity. Monitoring this helps investors assess the company's ability to raise capital through equity-linked instruments.